Prelude Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,348 | 0.0061% |
Individual Insiders | 3,265,486 | 5.94% |
General Public | 3,965,557 | 7.22% |
Institutions | 9,678,837 | 17.6% |
VC/PE Firms | 16,589,442 | 30.2% |
Hedge Funds | 21,426,897 | 39% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,293,897 | US$64.9m | 0% | 0.72% | |||
16,589,442 | US$62.2m | 0% | 0.9% | |||
4,133,000 | US$15.5m | 0% | 0.28% | |||
2,568,287 | US$9.6m | 0% | 0.52% | |||
2,163,369 | US$8.1m | 0% | no data | |||
1,097,474 | US$4.1m | 0.17% | no data | |||
1,016,999 | US$3.8m | 1.01% | no data | |||
941,971 | US$3.5m | -9.66% | no data | |||
551,776 | US$2.1m | 0% | no data | |||
508,149 | US$1.9m | -0.51% | no data | |||
500,098 | US$1.9m | 0% | no data | |||
361,632 | US$1.4m | 3.51% | no data | |||
320,394 | US$1.2m | 0% | 0.44% | |||
312,048 | US$1.2m | 1.58% | no data | |||
294,271 | US$1.1m | -0.87% | no data | |||
244,800 | US$918.0k | 13.1% | no data | |||
211,441 | US$792.9k | -0.37% | no data | |||
180,685 | US$677.6k | 2.85% | no data | |||
160,652 | US$602.4k | 0% | no data | |||
127,370 | US$477.6k | 2.14% | no data | |||
123,600 | US$463.5k | -16.9% | 0.01% | |||
122,147 | US$458.1k | 7.06% | no data | |||
101,850 | US$381.9k | 5.04% | no data | |||
72,262 | US$271.0k | 2.99% | no data | |||
70,200 | US$263.2k | 13.6% | no data |